NASDAQ Composite opens in less than two hours and Seattle Genetics’s pre-market value is already 2.35% up.

The last session, NASDAQ Composite ended with Seattle Genetics falling 0.47% to $175.86. NASDAQ Composite fell 0.12% to $13,112.64, following last session’s downward trend on what was a somewhat negative trend exchanging session.

Seattle Genetics’s last close was $176.69, 21.65% under its 52-week high of $213.94.

Seattle Genetics’s Sales

Seattle Genetics’s sales growth is 101.2% for the present quarter and 60.8% for the next. The company’s growth estimates for the present quarter and the next is 521.4% and 72.4%, respectively.

Seattle Genetics’s Revenue

Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.

Seattle Genetics’s Stock Yearly Top and Bottom Value

Seattle Genetics’s stock is valued at $175.86 at 07:37 EST, way under its 52-week high of $213.94 and way higher than its 52-week low of $90.57.

Seattle Genetics’s Moving Average

Seattle Genetics’s worth is under its 50-day moving average of $182.72 and under its 200-day moving average of $176.63.

Volatility

Seattle Genetics’s last day, last week, and last month’s average volatility was a negative 2.08%, a positive 1.19%, and a negative 0.38%, respectively.

Seattle Genetics’s last day, last week, and last month’s high and low average amplitude percentage was 2.28%, 3.27%, and 3.07%, respectively.

LEAVE A REPLY

Please enter your comment!
Please enter your name here